Equities

Kalbe Farma Tbk PT

Kalbe Farma Tbk PT

Actions
  • Price (EUR)0.074
  • Today's Change-0.001 / -1.33%
  • Shares traded0.00
  • 1 Year change-38.33%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Kalbe Farma Tbk PT (LCLA:FRA) traded at 0.074, 17.46% above the 52 week low of 0.063 set on Oct 31, 2023.
52-week range
Today
0.063Oct 31 20230.136Jun 14 2023
Open0.074
High0.074
Low0.074
Bid0.074
Offer0.0885
Previous close0.075
Average volume0.00
Shares outstanding46.88bn
Free float19.58bn
P/E (TTM)23.65
Market cap66.33tn IDR
EPS (TTM)59.83
IDR
Annual div (ADY)0.0023
EUR
Annual div yield (ADY)3.17%
Div ex-dateMay 12 2023
Div pay-dateMay 31 2023
Data delayed at least 15 minutes, as of Apr 19 2024 14:29 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.